Study on optical properties of novel Ru(II) complex

A novel Ru(II) complex composed of Ruthenium and 3 ligands has been successfully synthesized. The ligands are firstly synthesized ; the ligand 1,10-phenanthroline-5-carboxylic acid (compound D) acts as an anchor for connecting with different compound (for example, connecting with the quantum dots) whereas the 2 other ligands  (compound H)  playing important role for linear and non-linear optical properties. Secondly, these ligands (compound H, compound D) are attached to initiator Ru salt, respectively. Optical properties of this novel Ru(II) complex were investigated via absorption, luminescent measurements. Additionally, I also used theoritical calculation TDDFT (time dependent density functional theory) to display frontier molecular orbitals of ligands for linear and non-linear optical properties, to assign electronic transitions in absorption spectra of complex. Significant result is luminescence intensity dependent on the dioxygen concentration, ascribed to the luminescence from 3MLCT state, centered at 600 nm. Energy transfer between 3MLCT state and the fundamental triplet state of dioxygen can be studied in order to evaluate the photosensitizing ablities of the complex. This complex can also be used as oxygen concentration sensor at a given temperature. Keywords. Ru(II) complex, ligands, anchor, luminescence, quantum dot

Determinants of Access to Credit by the Small Business at Binh Thuy District, Can Tho City, Vietnam

This paper investigates the “Determinants of households’ business access to bank credit in Binh Thuy district, Can Tho city” which is performed by using the method of directly interviewing 240 business households in 8 wards in Binh Thuy district. By using the Logistics models, the finding show that the access to credit by small business households are significantly affected by education level of householders, capital of household businesses, collateral and income of businesses household. In addition, based on given results, possible solutions to improve the access to credit for business households at Binh Thuy district, Can Tho city have been considered

Red light emission of Mn doped beta-tricalcium phosphate -Ca3(PO4)2

This paper is the first report on the red light emission of manganese (Mn) doped beta-tricalcium phosphate (b-Ca3(PO4)2, TCP) synthesis by co-precipitation method followed by thermal annealing. The annealed Mn doped TCP phosphor showed dominant spheres with a diameter of about 500 nm. The influences of the Mn concentration, annealing temperature, and atmospheres on the photoluminescence intensities of the phosphors were investigated and the results indicate that the annealing temperatures and Mn concentrations are the main factors. The phosphor showed visible emission peaks appeared at about 660 nm and 580 nm results in from the 4T1-6A1 transitions within Mn2+ ion. The Mn-TCP phosphor may serve as a candidate for light-emitting diode application in agriculture lighting. Keywords. Hydroxyapatite; manganese; luminescence; tricalcium phosphate

Formation during glycine-nitrate combustion and magnetic properties of YFe1–xNixO3 nanoparticles

The synthesis of FeO3 and YFe1–xNixO3 (x = 0.1; 0.15; 0.2; 0.3; 0.5) nanocrystals was performed under the conditions of a self-propagating wave of glycine-nitrate combustion and their characterization and determination of the effect of Ni2+ doping of yttrium ferrite on the magnetic properties of nanopowders. The technology for the synthesis of yttrium orthoferrite nanoparticles (with and without doping with Ni2+ ions) by the glycine-nitrate combustion method at a ratio of G/N = 1 and 1.5 without adding a gelling agent to the reaction mixture and using ethylene glycol/glycerol is described. For the characterization of nanopowders based on YFeO3, the following were determined: phase composition and crystal structure (X-ray diffraction (XRD) method); size and structure of nanocrystal particles (transmission electron microscopy (TEM)); elemental composition of the samples (local X-ray spectral microanalysis (LXSMA)); magnetic characteristics (field dependences of specific magnetization). Thermal annealing of the synthesized samples at 800°C for 60 min led to the formation of the о-YFeO3 main phase. Undoped samples of yttrium orthoferrite were characterized by a particle diameter in the range of 5-185 nm, depending on the gelling agent used. YFe1-xNixO3 particles had a predominantly round shape with a size of 24 to 31 nm; the non-monotonic dependence of the average particle diameter on the dopant content was revealed: as the amount of dopant added increased, the average crystallite size tended to decrease. Nanopowders of undoped yttrium orthoferrite exhibit antiferromagnetic behaviour of magnetic susceptibility with temperature. The change in the magnetic properties of the nickel-doped YFeO3 nanocrystalline powders was due to the incorporation of Ni2+ into the Fe3+position, which led to the formation of a material with more pronounced soft magnetic properties at a substitution degree of 0.1. Samples with high degrees of substitution (x = 0.15 and 0.3) were also characterized by paramagnetic behaviour at temperatures above 100 K

Awareness and preparedness of healthcare workers against the first wave of the COVID-19 pandemic: A cross-sectional survey across 57 countries.

BACKGROUND: Since the COVID-19 pandemic began, there have been concerns related to the preparedness of healthcare workers (HCWs). This study aimed to describe the level of awareness and preparedness of hospital HCWs at the time of the first wave. METHODS: This multinational, multicenter, cross-sectional survey was conducted among hospital HCWs from February to May 2020. We used a hierarchical logistic regression multivariate analysis to adjust the influence of variables based on awareness and preparedness. We then used association rule mining to identify relationships between HCW confidence in handling suspected COVID-19 patients and prior COVID-19 case-management training. RESULTS: We surveyed 24,653 HCWs from 371 hospitals across 57 countries and received 17,302 responses from 70.2% HCWs overall. The median COVID-19 preparedness score was 11.0 (interquartile range [IQR] = 6.0-14.0) and the median awareness score was 29.6 (IQR = 26.6-32.6). HCWs at COVID-19 designated facilities with previous outbreak experience, or HCWs who were trained for dealing with the SARS-CoV-2 outbreak, had significantly higher levels of preparedness and awareness (p<0.001). Association rule mining suggests that nurses and doctors who had a 'great-extent-of-confidence' in handling suspected COVID-19 patients had participated in COVID-19 training courses. Male participants (mean difference = 0.34; 95% CI = 0.22, 0.46; p<0.001) and nurses (mean difference = 0.67; 95% CI = 0.53, 0.81; p<0.001) had higher preparedness scores compared to women participants and doctors. INTERPRETATION: There was an unsurprising high level of awareness and preparedness among HCWs who participated in COVID-19 training courses. However, disparity existed along the lines of gender and type of HCW. It is unknown whether the difference in COVID-19 preparedness that we detected early in the pandemic may have translated into disproportionate SARS-CoV-2 burden of disease by gender or HCW type

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke